These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15207259)

  • 1. The mouse ortholog of the neuronal ceroid lipofuscinosis CLN5 gene encodes a soluble lysosomal glycoprotein expressed in the developing brain.
    Holmberg V; Jalanko A; Isosomppi J; Fabritius AL; Peltonen L; Kopra O
    Neurobiol Dis; 2004 Jun; 16(1):29-40. PubMed ID: 15207259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuronal ceroid lipofuscinosis protein CLN5: new insights into cellular maturation, transport, and consequences of mutations.
    Schmiedt ML; Bessa C; Heine C; Ribeiro MG; Jalanko A; Kyttälä A
    Hum Mutat; 2010 Mar; 31(3):356-65. PubMed ID: 20052765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging.
    Kopra O; Vesa J; von Schantz C; Manninen T; Minye H; Fabritius AL; Rapola J; van Diggelen OP; Saarela J; Jalanko A; Peltonen L
    Hum Mol Genet; 2004 Dec; 13(23):2893-906. PubMed ID: 15459177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuronal ceroid lipofuscinosis Cln8 gene expression is developmentally regulated in mouse brain and up-regulated in the hippocampal kindling model of epilepsy.
    Lonka L; Aalto A; Kopra O; Kuronen M; Kokaia Z; Saarma M; Lehesjoki AE
    BMC Neurosci; 2005 Apr; 6():27. PubMed ID: 15826318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis.
    Savukoski M; Klockars T; Holmberg V; Santavuori P; Lander ES; Peltonen L
    Nat Genet; 1998 Jul; 19(3):286-8. PubMed ID: 9662406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue.
    Pohl S; Mitchison HM; Kohlschütter A; van Diggelen O; Braulke T; Storch S
    J Neurochem; 2007 Dec; 103(6):2177-88. PubMed ID: 17868323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation in canine CLN5 causes neuronal ceroid lipofuscinosis in Border collie dogs.
    Melville SA; Wilson CL; Chiang CS; Studdert VP; Lingaas F; Wilton AN
    Genomics; 2005 Sep; 86(3):287-94. PubMed ID: 16033706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal ceroid lipofuscinosis genes, CLN2, CLN3 and CLN5 are spatially and temporally co-expressed in a developing mouse brain.
    Fabritius AL; Vesa J; Minye HM; Nakano I; Kornblum H; Peltonen L
    Exp Mol Pathol; 2014 Dec; 97(3):484-91. PubMed ID: 25303899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLN5 mutations are frequent in juvenile and late-onset non-Finnish patients with NCL.
    Xin W; Mullen TE; Kiely R; Min J; Feng X; Cao Y; O'Malley L; Shen Y; Chu-Shore C; Mole SE; Goebel HH; Sims K
    Neurology; 2010 Feb; 74(7):565-71. PubMed ID: 20157158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cln5-deficiency in mice leads to microglial activation, defective myelination and changes in lipid metabolism.
    Schmiedt ML; Blom T; Blom T; Kopra O; Wong A; von Schantz-Fant C; Ikonen E; Kuronen M; Jauhiainen M; Cooper JD; Jalanko A
    Neurobiol Dis; 2012 Apr; 46(1):19-29. PubMed ID: 22182690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positional cloning of the CLN5 gene defective in the Finnish variant of the LINCL.
    Klockars T; Savukoski M; Isosomppi J; Peltonen L
    Mol Genet Metab; 1999 Apr; 66(4):324-8. PubMed ID: 10191122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of storage pathology in prenatal CLN5-deficient sheep neural cultures by lentiviral gene therapy.
    Hughes SM; Hope KM; Xu JB; Mitchell NL; Palmer DN
    Neurobiol Dis; 2014 Feb; 62():543-50. PubMed ID: 24269732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein.
    Isosomppi J; Vesa J; Jalanko A; Peltonen L
    Hum Mol Genet; 2002 Apr; 11(8):885-91. PubMed ID: 11971870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
    Bernardini F; Warburton MJ
    Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topology and membrane anchoring of the lysosomal storage disease-related protein CLN5.
    Larkin H; Ribeiro MG; Lavoie C
    Hum Mutat; 2013 Dec; 34(12):1688-97. PubMed ID: 24038957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLN6, which is associated with a lysosomal storage disease, is an endoplasmic reticulum protein.
    Mole SE; Michaux G; Codlin S; Wheeler RB; Sharp JD; Cutler DF
    Exp Cell Res; 2004 Aug; 298(2):399-406. PubMed ID: 15265688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmembrane protein 50b (C21orf4), a candidate for Down syndrome neurophenotypes, encodes an intracellular membrane protein expressed in the rodent brain.
    Moldrich RX; Lainé J; Visel A; Beart PM; Laffaire J; Rossier J; Potier MC
    Neuroscience; 2008 Jul; 154(4):1255-66. PubMed ID: 18541381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.
    Chan CH; Ramirez-Montealegre D; Pearce DA
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral-mediated delivery of the late-infantile neuronal ceroid lipofuscinosis gene, TPP-I to the mouse central nervous system.
    Haskell RE; Hughes SM; Chiorini JA; Alisky JM; Davidson BL
    Gene Ther; 2003 Jan; 10(1):34-42. PubMed ID: 12525835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two novel CLN5 mutations in a Portuguese patient with vLINCL: insights into molecular mechanisms of CLN5 deficiency.
    Bessa C; Teixeira CA; Mangas M; Dias A; Sá Miranda MC; Guimarães A; Ferreira JC; Canas N; Cabral P; Ribeiro MG
    Mol Genet Metab; 2006 Nov; 89(3):245-53. PubMed ID: 16814585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.